What are the standing orders for treating a patient with acute viral gastroenteritis (stomach virus)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 2, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Standing Orders for Acute Viral Gastroenteritis

Oral rehydration solution (ORS) is the first-line treatment for all patients with viral gastroenteritis and mild-to-moderate dehydration, with intravenous fluids reserved only for severe dehydration, shock, or failure of oral rehydration. 1

Immediate Assessment and Hydration Strategy

Assess Dehydration Severity

  • Mild-to-moderate dehydration: Normal or slightly decreased mental status, moist mucous membranes, normal or slightly decreased urine output, capillary refill <2 seconds 1
  • Severe dehydration: Altered mental status, sunken eyes, dry mucous membranes, markedly decreased or absent urine output, delayed capillary refill, weak pulse, hypotension 1

Rehydration Protocol by Severity

For Mild-to-Moderate Dehydration:

  • Infants and children: Administer ORS 50-100 mL/kg over 3-4 hours 1
  • Adolescents and adults (≥30 kg): Administer ORS 2-4 L over 3-4 hours 1
  • Maintenance after rehydration:
    • Children <10 kg: 60-120 mL ORS per diarrheal stool or vomiting episode (up to ~500 mL/day) 1
    • Children >10 kg: 120-240 mL ORS per episode (up to ~1 L/day) 1
    • Adults: Ad libitum up to ~2 L/day 1

For Severe Dehydration:

  • Immediate IV access: Administer isotonic crystalloid (normal saline or lactated Ringer's) boluses of 20 mL/kg until pulse, perfusion, and mental status normalize 1
  • Malnourished infants: Use smaller-volume frequent boluses of 10 mL/kg due to reduced cardiac output capacity 1
  • After stabilization: Transition to ORS for remaining deficit replacement 1

Antiemetic Therapy

Ondansetron administration:

  • Indication: Children >4 years and adolescents with significant vomiting that impairs oral rehydration tolerance 2
  • Dosing: Weight-based dosing per institutional protocol
  • Benefit: Facilitates oral rehydration, reduces need for IV fluids and hospitalization 3, 4
  • Caveat: Use of ondansetron may prevent some minor criteria (pallor, lethargy) from manifesting, which could mask severity assessment 1

Dietary Management

Feeding instructions:

  • Continue breastfeeding throughout illness without interruption 1, 2
  • Resume age-appropriate diet immediately after rehydration is complete; offer food every 3-4 hours 1
  • Do not dilute formula: Children on lactose-containing formula can tolerate the same product in most cases 1
  • Lactose-free diet: Consider only if symptoms persist beyond 10-14 days post-rotavirus infection, as mild lactose intolerance may occur 2, 5

Medications to AVOID

Antimotility agents:

  • Loperamide is contraindicated in all children <18 years with acute diarrhea 2, 5
  • In adults: Loperamide may be considered only for immunocompetent patients with acute watery diarrhea, but avoid if fever or bloody diarrhea present 2, 5

Infection Control Measures

Mandatory precautions:

  • Handwashing: Vigorous soap and water handwashing for at least 10 seconds after toilet use, diaper changes, and before food handling 2
  • Staff exclusion: Symptomatic healthcare workers must be excluded from patient contact for at least 2 days after symptom resolution 2, 5
  • Patient isolation: Separate ill patients from well individuals until 2 days after symptom resolution 2, 5
  • Environmental cleaning: Disinfect surfaces soiled by feces or vomitus 2, 5

Indications for IV Therapy and Hospitalization

Escalate to IV fluids when:

  • Severe dehydration with signs of shock (altered mental status, hypotension, poor perfusion) 1
  • Failure of oral rehydration therapy plus antiemetic 3, 4
  • Presence of ileus preventing oral intake 1
  • Ketonemia requiring initial IV hydration to enable oral tolerance 1

Consider nasogastric ORS administration before IV therapy in patients with moderate dehydration who cannot tolerate oral intake but have normal mental status 1, 6

Laboratory Testing

Routine testing NOT indicated for:

  • Mild symptoms with likely viral etiology 3, 7
  • Symptoms resolving within one week 7

Testing IS indicated for:

  • Bloody diarrhea (atypical for viral gastroenteritis) 5, 7
  • Severe or prolonged symptoms (>7 days) 7
  • Recent antibiotic exposure (test for Clostridioides difficile) 7
  • Immunocompromised patients 5

Critical Pitfalls to Avoid

  • Do not delay ORS waiting for laboratory results; begin rehydration immediately based on clinical assessment 2, 5
  • Do not use popular beverages (apple juice, Gatorade, commercial soft drinks) as ORS substitutes; use proper low-osmolarity ORS formulations (Pedialyte, CeraLyte, Enfalac Lytren) 1
  • Do not use rectal swabs for viral diagnosis if testing is needed; they have no diagnostic value 1, 5
  • Do not assume viral etiology if bloody diarrhea is present; this requires investigation for bacterial or other causes 5

Special Population Considerations

Elderly patients:

  • Require heightened attention to hydration status, especially those on diuretic medications 2, 5
  • Higher risk for dehydration and electrolyte imbalances 2, 5

Pregnant women:

  • No specific threat beyond dehydration risks; viremic states do not occur with gastroenteritis viruses 2, 5
  • Transplacental exposure risk is minimal to nonexistent 2, 5

Immunocompromised patients:

  • If CMV gastroenteritis suspected (requires endoscopic biopsy confirmation), initiate ganciclovir 5 mg/kg IV twice daily for 2-3 weeks 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment for Viral Gastroenteritis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Gastroenteritis in Children.

American family physician, 2019

Research

Acute gastroenteritis: evidence-based management of pediatric patients.

Pediatric emergency medicine practice, 2018

Guideline

Treatment of Viral Gastritis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Acute Infectious Gastroenteritis in Infancy and Childhood.

Deutsches Arzteblatt international, 2020

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.